Welcome to CDC Stacks | Development of new vaccines for tuberculosis; recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET) - 13480 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Development of new vaccines for tuberculosis; recommendations of the Advisory Council for the Elimination of Tuberculosis (ACET)
  • Published Date:
    August 21, 1998
Filetype[PDF - 170.84 KB]


Details:
  • Personal Authors:
  • Corporate Authors:
    Advisory Council for the Elimination of Tuberculosis (U.S.) ; Centers for Disease Control and Prevention (U.S.) ;
  • Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v.47, no. RR-13
  • Document Type:
  • Description:
    Introduction -- Current control measures -- Eliminating tuberculosis -- Progress in vaccine development -- Needs and recommendations -- Conclusion -- References.

    Tuberculosis (TB) remains a major, global public health problem, particularly in low-income countries. Better application of current diagnostic, treatment, and prevention strategies could lead to gradual decreases in the disease, but eliminating TB completely in the United States and internationally will require new tools. The greatest impact could come from a new vaccine, and recent technological advances have provided the basis for new vaccine development. However, sustained support is required to move the research from the laboratory to field trials of vaccines and to implement new vaccine programs. Recognizing the importance of TB vaccines, the Advisory Council for the Elimination of Tuberculosis (ACET) recommends that public agencies and vaccine manufacturers develop a comprehensive, consensual strategy to achieve these goals. This report outlines the elements that should be considered in devising a strategic plan for vaccine development.

  • Supporting Files:
    No Additional Files